Neil Dahiya

Boston Scientific Revises Cryoablation Catheter Guidelines Following Fatal Incidents

The FDA has communicated a notification informing users about the revisions made by Boston Scientific (NYSE: BSX) to the instructions for their PolarX cryoablation catheters. This measure involves updating the instructions for use (IFU), rather than withdrawing the product from

Boston Scientific Revises Cryoablation Catheter Guidelines Following Fatal Incidents Read More »